5 Stocks Gaining Ground on Thursday

1. Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) is 42% in the green as of 12:57 PM ET after the Pao Alto, California-based biotech company revealed that Peginterferon Lambda reduces the risk of hospitalization or staying in the emergency room for longer than six hours by 50% for cases related to COVID-19. It was also revealed that the risk of death was also reduced by 60% in Phase 3 TOGETHER study, which comprises a double-blind, multi-center, placebo-controlled, and randomized study of non-hospitalized patients with COVID-19, who have a high likelihood of developing a severe illness. The primary target was achieved across all variants of COVID-19 till today, including the omicron variant. Based on this, Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) believes that Lambda will also be effective for all upcoming variants of COVID-19. The company intends to share this finding with the FDA and also submit an Emergency Use Authorization request with the drug regulatory authority soon. Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) was held by 11 hedge funds at the end of Q4 2021, down from 14 in the previous quarter.

You can also take a peek at the 10 Best Dow Dividend Stocks to Double Your Income and Sanctions on Russia Are Affecting These 10 Stocks.

Follow Insider Monkey on Twitter